StreetAlpha
Amneal Pharmaceuticals, Inc. · SEC Form 4

AMRX Insider Trading

From SEC Form 433 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Amneal Pharmaceuticals, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $7.7M sold.

← AMRX stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$7.7M4 sales · 4 insiders
Net−$7.7Mbought minus sold
Planned sales–of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
DecJanFebMarApr2026-05: sold $451KMayJunJul2026-08: sold $7.2MAugSepOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when AMRX insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an AMRX officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every AMRX insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Aug 13, 2026John KielyDirectorSale50,000$17.64$882K210,252Aug 14Form 4
Aug 12, 2026Jason B. DalyEVP, Chief Legal OfficerSale216,613$17.41$3.8M35,171Aug 13Form 4
Aug 12, 2026Nikita ShahExecutive Vice PresidentSale146,403$17.51$2.6M253,390Aug 13Form 4
May 11, 2026Deborah M. AutorDirectorSale34,819$12.94$451K93,660May 12Form 4
Nov 17, 2025Ted C NarkDirectorSale50,000$11.72$586K291,029Nov 19Form 4
Nov 12, 2025Nikita ShahExecutive Vice PresidentSale131,856$11.92$1.6M146,403Nov 14Form 4
Aug 27, 2025John KielyDirectorSale32,000$9.23$295K225,433Aug 28Form 4
Aug 25, 2025Nikita ShahExecutive Vice PresidentSale120,832$9.65$1.2M146,403Aug 25Form 4
Aug 20, 2025Andrew S BoyerExecutive Vice PresidentSale279,244$9.38$2.6M152,426Aug 22Form 4
Aug 15, 2025Tasos KonidarisExecutive Vice President & CFOSale499,730$9.33$4.7M122,152Aug 15Form 4
Aug 14, 2025Nikita ShahExecutive Vice PresidentSale71,694$9.29$666K267,235Aug 15Form 4
Aug 12, 2025Andrew S BoyerExecutive Vice PresidentSale33,436$9.05$303K256,670Aug 13Form 4
Aug 12, 2025Jason B. DalyEVP, Chief Legal OfficerSale22,000$9.05$199K10,606Aug 13Form 4
Aug 12, 2025Nikita ShahExecutive Vice PresidentSale50,000$9.04$452K338,929Aug 13Form 4
Jun 16, 2025Gautam PatelDirectorSale plan94,906$8.02$761K1,609,144Jun 18Form 4
🔒 18 more trades. Create a free account or sign in to see them all.

AMRX insider trading FAQ

Are AMRX insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of AMRX on the open market in 0 trades, and 4 sold $7.7M in 4 trades.

When did an AMRX insider last buy shares?

There has been no open market insider purchase of AMRX in the last two years.

When did an AMRX insider last sell shares?

John Kiely (Director) sold 50,000 shares for $882K on Aug 13, 2026.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice